Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2025-12-24 @ 4:31 PM
Study NCT ID:
NCT02950766
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-05
First Post:
2016-09-08
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
Sponsor:
Patrick Ott, MD, PhD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-03
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05-30
Completion Date Type:
ESTIMATED
First Submit Date:
2016-09-08
First Submit QC Date:
None
Study First Post Date:
2016-11-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-03
Last Update Post Date:
2025-03-05
Last Update Post Date Type:
ACTUAL